Not every REIT rally is built the same. Some are just rate-cut trades. Others are backed by real property-level growth, stronger cash flow, and better earnings visibility.
This one falls into the second camp. The stock is already near its highs, so the entry matters, but the underlying business keeps giving investors reasons to stay interested.
Income Strategy (Sponsored)
His official paycheck? $400,000 a year.
But the real story is somewhere else: As much as $250,000 per month… from a single source.
It’s not real estate. It’s not the stock market.
So what’s actually producing this level of cash flow and why are more investors turning to it today?
Discover how to get started for less than $20.
What Just Happened
Earnings estimates are moving higher
American Healthcare REIT, Inc. (NYSE: AHR) was recently upgraded to a Zacks Rank #2 Buy, driven by positive earnings estimate revisions. That matters because estimate revisions are often one of the clearest signals that analysts are getting more confident in the underlying business.
For a REIT, this is especially important. Investors are not just looking at GAAP earnings. They care about funds from operations, same-store net operating income, occupancy, rent growth, acquisitions, and balance-sheet strength.
The upgrade suggests the earnings story is still moving in the right direction.
Q1 gave investors a clean report
The latest quarter backed up that optimism. AHR reported GAAP net income attributable to controlling interest of $23.7 million, or $0.13 per diluted share.
More importantly for REIT investors, normalized FFO attributable to common stockholders was $0.50 per diluted share, up more than 30% from the same period last year.
That is the number to focus on. GAAP earnings can be noisy for real estate companies because of depreciation and other accounting items. Normalized FFO gives a better look at the recurring cash-flow engine.
Guidance moved higher
Management also raised full-year 2026 guidance. AHR now expects normalized FFO of $2.03 to $2.09 per diluted share and total portfolio same-store NOI growth of 9% to 12%.
That is a strong update. A REIT trading near its highs needs guidance support, and AHR gave the market exactly that.
Why The Business Matters
Healthcare real estate has a structural tailwind
The long-term setup is simple: the U.S. population is aging, and healthcare real estate demand is growing with it. Senior housing, integrated care campuses, outpatient medical buildings, and skilled healthcare real estate all benefit from demographic pressure.
That does not make every operator a winner. Execution still matters. But the demand backdrop is more durable than many other real estate categories.
Senior housing is doing the heavy lifting
The biggest strength in the portfolio right now is senior housing. AHR’s senior housing operating properties segment posted same-store NOI growth of 19.7% in Q1. Its integrated senior health campuses segment also delivered 14.5% same-store NOI growth.
Those are excellent property-level numbers. They show that growth is not just coming from acquisitions or financial engineering. The existing assets are performing better.
The portfolio has multiple income streams
AHR owns a mix of senior housing operating properties, integrated senior health campuses, outpatient medical assets, and triple-net leased healthcare properties. That gives the company more than one way to generate cash flow.
The senior housing operating portfolio provides upside when occupancy, rates, and margins improve. Triple-net leases add more stable rental income.
Outpatient medical properties bring exposure to healthcare services outside hospitals. That mix helps balance growth and stability.
When comparing two stocks in the same sector, what do you weigh most?
Tax Strategy (Sponsored)
Capital gains taxes can take a bigger bite out of your profits than expected.
Fortunately, some deductions may help reduce the impact — including:
Investment-related expenses
Certain real estate selling costs
Because rules and eligibility vary, many investors turn to fiduciary financial advisors for guidance.
Find an Advisor Match.
Why The Stock Has A Case
Same-store NOI growth is the hook
Same-store NOI growth of 12.1% across the total portfolio is a major reason the stock has worked. In REITs, property-level growth is the foundation. If same-store NOI is growing, asset values and cash flow can follow.
The stronger piece is that management raised full-year same-store NOI guidance to 9% to 12%. That tells investors the Q1 strength was not just a one-quarter fluke.
The balance sheet improved
AHR improved net debt to annualized adjusted EBITDA from 3.4 times at the end of 2025 to 3.0 times at the end of Q1. That matters because REIT investors are sensitive to leverage, especially when interest rates remain a major part of the market debate.
Lower leverage gives the company more flexibility to fund acquisitions, support the dividend, and manage the portfolio without leaning too hard on debt.
The dividend is covered
AHR pays a quarterly dividend of $0.25 per share, or $1.00 annually. Compared with the midpoint of 2026 normalized FFO guidance, the payout ratio looks manageable.
The yield is not huge for a REIT, but that is partly because the stock has already performed well. Investors are not buying this mainly for a massive current yield. They are buying it for cash-flow growth, healthcare real estate demand, and dividend durability.
Elite Trade Club Insider
A $160 Million Holder Sale And A $25 Million Insider Buy Just Hit Two Hot Healthcare Stocks
You’re watching two healthcare charts that already look expensive from the outside. One just hit a fresh high with analysts raising targets, while the other is sitting near its 52-week high after a huge biotech run. But Elite Trade Club Insider readers are seeing the part most investors miss: one major holder is cashing out hard, while one director is buying nearly $25 million near the highs.
You’re reading the free version. Here’s what we held back.
Every day, insiders and institutions move millions before the market catches on. We surface the data behind those moves before the rest of the market sees it.
A subscription gets you:
The insider buys, options bets, and dark pool moves the free edition can't show you. Unlocked every weekday.
A Sunday Deep Dive that tells you where to look before Monday's bell rings.
The Friday Smart Money Brief: who bought, who sold, where the big options bets landed, and where institutions are hiding volume. Three data layers. One email.
A Monthly Insider Scorecard so you always know whether smart money is buying or selling the market.
Every past Insider edition, unlocked, on elitetrade.club. Go back and see what you missed.
$25/mo or $250/yr. 30-day money back guarantee. Cancel anytime. Founding member pricing: lock in $25/mo before we raise it.
What Has To Go Right
Senior housing momentum needs to continue
This is the main driver. AHR needs continued occupancy gains, pricing power, and expense control in its senior housing and integrated campus assets. If those segments keep compounding NOI, the stock can hold its premium.
Guidance needs to stay intact
The raised 2026 guidance is now the market’s scoreboard. Investors need normalized FFO to land within or above the $2.03 to $2.09 range. A guidance cut would hurt because the stock is already priced for solid execution.
Capital deployment needs to stay accretive
AHR acquired about $162.8 million of new investments in the SHOP segment during Q1. Growth through acquisitions can work, but only if management buys assets at attractive returns and funds them wisely.
The company has also been active in equity issuance through its ATM program. That can be smart if the stock trades well and proceeds fund accretive deals, but investors need to watch dilution.
High-Rate AI (Sponsored)
Louis Navellier’s proprietary Stock Grader system helped flag major winners years before they became household names.
Now, that same $9 million system is flashing its highest rating on one AI stock with 28% year-over-year sales growth and more than 30,000 patents.
He is giving away the name, ticker, and full analysis for free.
See the free AI stock pick here.
What Could Trip It Up
The valuation is no longer cheap
At $52, the stock trades around 25 times the midpoint of 2026 normalized FFO guidance. That is a premium multiple for a REIT. It can be justified if growth stays strong, but it leaves less room for disappointment.
The dividend yield is modest
A yield near 2% is low for income-focused REIT investors. That means the stock needs growth to carry the total return story. If growth slows, the low yield will not provide much downside cushion.
Senior housing can be operationally messy
Senior housing upside is real, but it is not risk-free. Labor costs, occupancy swings, regulatory pressure, and operator execution all matter. Strong NOI growth can fade quickly if expenses rise faster than rents.
Equity issuance can dilute shareholders
AHR has used its ATM program to raise capital. That can support growth, but it also increases the share count. The market will tolerate dilution if new investments are accretive. It will punish dilution if growth slows.
What I’d Watch Next
The first thing to watch is same-store NOI growth, especially in SHOP and integrated senior health campuses. Those are the segments powering the current story. The second is normalized FFO per share versus guidance.
The third is leverage, because the balance sheet improvement is part of the bull case. The fourth is acquisition activity and equity issuance. AHR needs to show that new capital is being deployed at attractive returns, not just used to grow for growth’s sake.
My Take
Buy on pullbacks. AHR is a high-quality healthcare real estate growth story with strong senior housing momentum, raised guidance, improving leverage, and a covered dividend.
The stock is not cheap after the move, but the operating trends are strong enough to keep it on the buy list.
The key risk is valuation. At this price, investors are paying for continued NOI growth and clean execution. If senior housing momentum slows, FFO guidance disappoints, or equity issuance becomes less accretive, the stock can pull back quickly.
But for investors looking for healthcare real estate exposure with real growth behind it, AHR still deserves attention.
Action Recap
🏥 Looking to buy? Buy on pullbacks. The business is strong, but the stock is close enough to its highs that entry price matters.
📈 Already own it? Keep holding while same-store NOI growth, FFO guidance, and leverage improvement stay on track.
⚠️ Main risk to respect: Valuation is the pressure point. If growth slows, the stock does not have a big dividend yield to cushion the downside.
That’s all for today. Thank you for reading. If you have any feedback, please reply to this email.
Best Regards,
— Adam Garcia
Elite Trade Club
Click here to get our daily newsletter straight to your cell for free.
P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.
